Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway

被引:48
|
作者
Liu, Yadong [1 ]
Lin, Fanlu [1 ,2 ]
Chen, Yaodong [3 ]
Wang, Rui [1 ]
Liu, Jiannan [1 ]
Jin, Yinshan [1 ]
An, Ruihua [1 ]
机构
[1] Harbin Med Univ, Dept Urol, Affiliated Hosp 1, 23 You Zheng St, Harbin 150001, Heilongjiang, Peoples R China
[2] Linyi Cent Hosp, Dept Urol, Linyi 276400, Shandong, Peoples R China
[3] Shanxi Med Univ, Hosp 1, Dept Ultrason Imaging, Taiyuan 030001, Shanxi, Peoples R China
来源
JOURNAL OF CANCER | 2020年 / 11卷 / 02期
关键词
cryptotanshinone; bladder cancer; proliferation; apoptosis; PTEN/PI3K/AKT; GROWTH; ANGIOGENESIS; SENSITIVITY; MIGRATION; TARGETS; PTEN;
D O I
10.7150/jca.31422
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cryptotanshinone (CTT), extracted from the root of Salvia miltiorrhiza Bunge (Danshen), exhibits activities against a variety of human cancers in vitro and in vivo. The purpose of this study was to investigate the potential inhibitory effect of CTT on bladder cancer. In this study, we found that CTT inhibited bladder cancer cell proliferation, migration, and invasion and promoted apoptosis. In addition, CTT modulated the expression of proteins via the PI3K/AKT pathway, and the inhibition of PI3K/AKT signalling was due to induction of PTEN expression. Taken together, the results of the present study demonstrated the anticancer effect of CTT on bladder cancer cells, which might be associated with the downregulation of PI3K/AKT/mTOR and NF-kappa B signalling pathway proteins, and this inhibition was mediated by the induction of PTEN.
引用
收藏
页码:488 / 499
页数:12
相关论文
共 50 条
  • [21] Cordycepin reverses cisplatin resistance in human bladder cancer cells via the PTEN/PI3K/AKt pathway
    Li, Sheng
    Zhou, Li-bin
    Wu, Tie-lin
    Yin, Min
    Long, Hui-min
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (05) : 965 - 970
  • [22] Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway
    Dong, Lei
    Liu, Feifei
    Liu, Dawei
    Kang, Shasha
    Yang, Xin
    Wang, Junxia
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2021, 57 (08) : 786 - 794
  • [23] MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer
    Hu, Mingli
    Zhu, Shixuan
    Xiong, Shengwei
    Xue, Xingxing
    Zhou, Xiaodong
    ONCOLOGY REPORTS, 2019, 41 (03) : 1439 - 1454
  • [24] Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway
    Lei Dong
    Feifei Liu
    Dawei Liu
    Shasha Kang
    Xin Yang
    Junxia Wang
    In Vitro Cellular & Developmental Biology - Animal, 2021, 57 : 786 - 794
  • [25] Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway
    Shi, Danning
    Li, Hongbo
    Zhang, Zeye
    He, Yueshuang
    Chen, Meng
    Sun, Liping
    Zhao, Piwen
    PLOS ONE, 2022, 17 (01):
  • [26] Exendin-4 Promotes Beta Cell Proliferation via PI3k/Akt Signalling Pathway
    Wang, Chaoxun
    Chen, Xiaopan
    Ding, Xiaoying
    He, Yanju
    Gu, Chengying
    Zhou, Ligang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (06) : 2223 - 2232
  • [27] Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer
    Li, Xiuming
    Liu, Hui
    Lv, Chengcheng
    Du, Jun
    Lian, Fangchao
    Zhang, Shouyi
    Wang, Zhiyong
    Zeng, Yu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [28] POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer
    Chen, Hualin
    Ma, Lin
    Yang, Wenjie
    Li, Yingjie
    Ji, Zhigang
    FASEB JOURNAL, 2023, 37 (12):
  • [29] Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway
    Wang, Sheng
    Lei, Yiqun
    Cai, Zeling
    Ye, Xiaoman
    Li, Lianhong
    Luo, Xiagang
    Yu, Chunzhao
    ONCOLOGY REPORTS, 2018, 40 (02) : 599 - 608
  • [30] Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway
    Lu, Jian-jun
    Su, Yao-wu
    Wang, Chao-jun
    Li, Di-feng
    Zhou, Liang
    TUMORI JOURNAL, 2019, 105 (03): : 231 - 242